Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 335,466 | 320,647 | 280,371 | 355,543 | 325,311 |
| Cost of Goods | 89,949 | 89,163 | 88,142 | 98,599 | 91,077 |
| Gross Profit | 245,517 | 231,484 | 192,229 | 256,944 | 234,234 |
| Operating Expenses | 197,847 | 206,535 | 194,166 | 175,073 | 172,131 |
| Operating Income | 48,619 | 25,112 | -1,795 | 82,470 | 62,180 |
| Interest Expense | 20,428 | 22,033 | 27,530 | 29,771 | 30,437 |
| Other Income | -40,521 | -13,074 | -5,458 | -105 | 372 |
| Pre-tax Income | -12,330 | -9,995 | -34,783 | 52,594 | 32,115 |
| Income Tax | -30,564 | -4,875 | -1,920 | -49,052 | -1,266 |
| Net Income Continuous | 18,234 | -5,120 | -32,863 | 101,646 | 33,381 |
| Net Income | $18,234 | $-5,120 | $-32,863 | $101,646 | $33,381 |
| EPS Basic Total Ops | 0.10 | -0.03 | -0.19 | 0.62 | 0.20 |
| EPS Basic Continuous Ops | 0.10 | -0.03 | -0.19 | 0.62 | 0.20 |
| EPS Diluted Total Ops | 0.09 | -0.03 | -0.19 | 0.63 | 0.19 |
| EPS Diluted Continuous Ops | 0.09 | -0.03 | -0.19 | 0.63 | 0.19 |
| EBITDA(a) | $113,385 | $90,009 | $62,947 | $150,966 | $130,542 |